Stock Scorecard



Stock Summary for Nevro Corp (NVRO) - $12.32 as of 4/19/2024 10:55:47 AM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NVRO

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NVRO

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NVRO

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for NVRO

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for NVRO

Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™ 4/2/2024 12:30:00 PM
Abbott ( ABT ) Expands in Canada With First Eterna SCS Use 3/25/2024 1:15:00 PM
Here's Why You Should Retain Nevro ( NVRO ) Stock for Now 3/21/2024 4:35:00 PM
Nevro ( NYSE:NVRO ) Upgraded to "Hold" at StockNews.com 3/1/2024 7:22:00 AM
Nevro ( NVRO ) Gets FDA Nod for SI Fixation Without Lateral Screw 2/29/2024 12:29:00 PM
Nevro ( NYSE:NVRO ) Downgraded by StockNews.com to "Sell" 2/23/2024 10:04:00 AM
Why Nevro Stock Lagged the Market on Thursday 2/22/2024 11:21:00 PM
Nevro's ( NVRO ) Q4 Earnings and Sales Top Estimates, Margins Up 2/22/2024 3:50:00 PM
Neuromodulation Market is Expected to Reach $11.0 Billion | MarketsandMarkets™ 2/22/2024 12:30:00 PM
Nevro ( NVRO ) Reports Q4 Loss, Tops Revenue Estimates 2/21/2024 10:20:00 PM

Financial Details for NVRO

Company Overview

Ticker NVRO
Company Name Nevro Corp
Country USA
Description Nevro Corp. The company is headquartered in Redwood City, California.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 12/31/2023
Next Earnings Date 4/24/2024

Stock Price History

Last Day Price 12.32
Last Day Price Updated 4/19/2024 10:55:47 AM EST
Last Day Volume 407,596
Average Daily Volume 425,967
52-Week High 34.86
52-Week Low 12.15
Last Price to 52 Week Low 1.40%

Valuation Measures

Trailing PE N/A
Industry PE 48.25
Sector PE 61.34
5-Year Average PE -812.66
Free Cash Flow Ratio 1.40
Industry Free Cash Flow Ratio 61.76
Sector Free Cash Flow Ratio 30.17
Current Ratio Most Recent Quarter 6.37
Total Cash Per Share 8.80
Book Value Per Share Most Recent Quarter 8.06
Price to Book Ratio 1.64
Industry Price to Book Ratio 5.21
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 1.13
Industry Price to Sales Ratio Twelve Trailing Months 14.23
Sector Price to Sales Ratio Twelve Trailing Months 5.19

Share Statistics

Total Shares Outstanding 36,681,400
Market Capitalization 451,914,848
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -3,172.31%
Reported EPS 12 Trailing Months -2.56
Reported EPS Past Year 0.00
Reported EPS Prior Year -2.57
Net Income Twelve Trailing Months -92,200,000
Net Income Past Year -92,200,000
Net Income Prior Year 3,001,000
Quarterly Revenue Growth YOY 2.00%
5-Year Revenue Growth 2.28%

Balance Sheet

Total Cash Most Recent Quarter 322,723,000
Total Cash Past Year 322,723,000
Total Cash Prior Year 374,385,000
Net Cash Position Most Recent Quarter 111,252,000
Net Cash Position Past Year 111,252,000
Long Term Debt Past Year 211,471,000
Long Term Debt Prior Year 186,867,000
Total Debt Most Recent Quarter 211,471,000
Equity to Debt Ratio Past Year 0.58
Equity to Debt Ratio Most Recent Quarter 0.58
Total Stockholder Equity Past Year 293,145,000
Total Stockholder Equity Prior Year 323,876,000
Total Stockholder Equity Most Recent Quarter 293,145,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.59
MACD Signal -0.58
20-Day Bollinger Lower Band 10.86
20-Day Bollinger Middle Band 16.75
20-Day Bollinger Upper Band 22.64
Beta 0.89
RSI 36.06
50-Day SMA 19.57
200-Day SMA 78.42

System

Modified 4/18/2024 7:30:58 AM EST